Integrin beta-6 (IB6) Sigvotatug Vedotin (SV) Translational and Pre-Clinical Research

  1. Funding & Proposal Support
  2. Find Funding
  3. Integrin beta-6 (IB6) Sigvotatug Vedotin (SV) Translational and Pre-Clinical Research
  4. Integrin beta-6 (IB6) Sigvotatug Vedotin (SV) Translational and Pre-Clinical Research

Key Information

Direct Link to Opportunity

https://cdn.pfizer.com/pfizercom/2025-01/GMG-2025-ONC-Global-IB6TranslationalPreclinical-RES-final.pdf?VersionId=zvcR0YkUuAxQHrRuunIGK4tRvFk8n2W9

Application Deadline

Amount:

$200,000

Fund Type

Grant

Funding Agency

Pfizer

Agency Type

Non-Federal

Internal or External

External

Status of Applicants

See Opportunity Website

Discipline(s)

See Opportunity Website

Contact

See Opportunity Website

Additional Details

Date Posted: